Turk Ilac ve Serum Sanayi AS Cash Flow-to-Debt Ratio
Turk Ilac ve Serum Sanayi AS cash flow-to-debt ratio. Turk Ilac ve Serum Sanayi AS (TRILC) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of TL44.50 Million could theoretically repay 0% of its total liabilities (TL4.21 Billion) in one year. Check Turk Ilac ve Serum Sanayi AS cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Turk Ilac ve Serum Sanayi AS (2018–2024)
Cash flow-to-debt ratio of Turk Ilac ve Serum Sanayi AS from 2018 to 2024. Historical debt coverage capacity for Turk Ilac ve Serum Sanayi AS across 7 annual periods. Check cash flow reinvestment rate of Turk Ilac ve Serum Sanayi AS to assess the company's total reinvestment commitment from operating cash flow.
Turk Ilac ve Serum Sanayi AS Cash Flow-to-Debt Ratio by Year (2018–2024)
Turk Ilac ve Serum Sanayi AS cash flow-to-debt ratio by year from 2018 to 2024. Year-by-year debt coverage analysis for Turk Ilac ve Serum Sanayi AS. For the full cash flow conversion analysis, see Turk Ilac ve Serum Sanayi AS cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (TRY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.18x | TL-378.48 Million | TL2.07 Billion | ▼ -146.8% |
| 2023 | 0.39x | TL408.19 Million | TL1.04 Billion | ▲ +1678.4% |
| 2022 | -0.02x | TL-11.88 Million | TL479.65 Million | ▲ +89.8% |
| 2021 | -0.24x | TL-71.67 Million | TL295.46 Million | ▼ -283.4% |
| 2020 | 0.13x | TL33.20 Million | TL250.99 Million | ▲ +100.5% |
| 2019 | 0.07x | TL13.32 Million | TL201.84 Million | ▼ -78.0% |
| 2018 | 0.30x | TL38.13 Million | TL127.38 Million | — |